台股 » 個股 » 佳醫 » 籌碼相關 » 券商分點績效

佳醫

(4104)
可現股當沖
  • 股價
    91.1
  • 漲跌
    ▼0.3
  • 漲幅
    -0.33%
  • 成交量
    148
  • 產業
    上市 生技醫療類股
  • 331人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
佳醫 (4104)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/22 ~ 2024/04/29     後一日»

券商獲利排行 - 2024/04/22 ~ 2024/04/29

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  0.99%118.116102.1-1161413091.990.89291.1
  1.00%38.539.1-0.50424192.191.692.691.1
  1.14%24.2024.2-2202392.292.692.291.1
  1.17%21.6021.6-1902092.292.392.291.1
  0.66%214.216.8-3233591.590.291.691.1
  1.95%14.310.53.8-25891.590.392.491.1
  1.28%14.2014.2-1201292.391.892.391.1
  0.31%13.2-1.214.4-4154691.591.791.591.1
  0.63%120122121090.590.5091.1
  1.31%11.83.88810290.490.19291.1
  1.83%10.20.79.5-51692.992.39391.1
  0.74%10.18.71.4-3121591.390.991.691.1
  0.31%9.54.45.1293459190.991.891.1
  0.95%8.75.13.6-361091.791.29291.1
  0.23%8.611.5-2.98413291.691.491.891.1
  0.07%8.313.6-5.31312711491.691.591.691.1
  0.80%8.11.26.9-651192.29292.391.1
  1.66%7.71.26.5-31592.591.592.791.1
  0.73%7.407.4-1101191.8091.891.1
  0.98%7.207.2-7089290.79291.1
  1.59%7.252.225390.69091.791.1
  0.43%71.85.3-1621891.390.691.491.1
  0.81%6.706.7-80991.891.491.891.1
  1.18%6.424.446290.3909191.1
  1.36%6.306.3-50592.4092.491.1
  1.30%606-40592.391.692.391.1
  1.07%5.905.9-506929192.191.1
  0.87%5.62.33.3-33791.791.191.991.1
  1.11%5.15.1005592.191.692.691.1
  0.82%4.62.22.3-2469291.792.391.1
  0.68%4.40.24.2-51791.891.691.891.1
  0.90%4.204.2-50591.990.491.991.1
  0.50%4.2-0.34.4-81991.791.991.791.1
  1.26%3.503.5-30392.3092.391.1
  0.93%3.43.4004491.49191.891.1
  1.83%3.33.3002290.89091.791.1
  1.18%3.21.71.5-11391.490.191.991.1
  1.12%3.103.1-203929192.191.1
  1.71%3.121.112190.7909291.1
  0.34%3.1-0.53.6-811091.59291.591.1
  1.65%32101291.490.192.191.1
  1.62%320.9-11291.3909291.1
  0.63%2.9-0.23.1-41591.992.191.991.1
  0.80%2.902.944090.490.4091.1
  1.52%2.802.8-20292.5092.591.1
  1.51%2.802.8-10292.591.792.591.1
  0.49%2.72.8-0.106591.591.291.891.1
  0.98%2.702.7-3039209291.1
  0.98%2.702.7-3039209291.1
  1.46%2.702.7-20292.5092.591.1

券商虧損排行 - 2024/04/22 ~ 2024/04/29

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.10%-74.9-25.7-49.24374309292.291.491.1
  -0.45%-51.1-1.6-49.5941253191.691.691.691.1
  -1.06%-35.20-35.23636092.192.190.991.1
  -1.66%-23.10-23.11515092.692.6091.1
  -1.21%-21.80-21.8-200209091.69091.1
  -0.30%-20.8-9.7-11.126775191.591.591.391.1
  -0.92%-16.6-4-12.6-1822090.692.490.491.1
  -0.75%-16.1-12.7-3.42232192.592.892.291.1
  -1.15%-15.50-15.5-1401590.192.490.191.1
  -1.82%-13.2-10.3-2.9-35890.992.290.191.1
  -0.90%-11.60-11.61314192929291.1
  -1.22%-110-11-100109009091.1
  -2.09%-9.6-6.2-3.425392.192.890.891.1
  -1.11%-9.20-9.299092.192.1091.1
  -1.04%-8.60-8.699092.192.1091.1
  -0.28%-7.8-2.6-5.213301791.491.591.391.1
  -0.60%-7.60.5-8-1121490.490.290.491.1
  -1.30%-70-7-60689.991.189.991.1
  -1.48%-6.70-6.7-40589.890.589.891.1
  -0.80%-6.6-3.1-3.549591.89291.391.1
  -1.40%-6.50-6.555092.492.4091.1
  -0.79%-6.40-6.4-80990.490.190.491.1
  -1.01%-6.40-6.4-70790.2090.291.1
  -1.08%-60-666092.192.1091.1
  -0.58%-5.8-5.800111190.290.589.991.1
  -0.33%-5.7-3.7-21319691.191.390.691.1
  -0.84%-5.30-5.3-60790.392.190.391.1
  -0.53%-5.30-5.31111091.691.6091.1
  -0.96%-5.20-5.2-50690.390.590.291.1
  -0.85%-4.6-2.9-1.7-23690.991.590.591.1
  -0.98%-4.50-4.55509292091.1
  -0.90%-4.10-4.155091.991.992.291.1
  -1.11%-4.10-4.144092.192.192.591.1
  -0.64%-4.10-4.177091.791.7091.1
  -1.06%-3.90-3.944092.192.1091.1
  -0.98%-3.6-2.3-1.314392.192.491.691.1
  -1.31%-3.50-3.5-20390.392.189.991.1
  -0.64%-3.5-1.9-1.626391.491.69191.1
  -0.74%-3.40-3.455091.891.8091.1
  -1.78%-3.30-3.322092.892.8091.1
  -0.87%-3.1-1.4-1.7-12490.59190.391.1
  -0.83%-30-344091.991.991.891.1
  -0.82%-30-344091.991.9091.1
  -1.05%-2.90-2.923092.192.191.691.1
  -0.64%-2.9-2-0.9-22591.191.890.891.1
  -1.01%-2.80-2.83309292091.1
  -1.00%-2.80-2.8330929292.391.1
  -0.98%-2.70-2.73309292091.1
  -0.97%-2.7-0.5-2.223192.192.291.791.1
  -1.44%-2.6-1.9-0.812191.491.99091.1
佳醫整併血液透析通路效益顯 下半年營運拚成長Anue鉅亨-2022/09/28
〈佳醫法說〉東南亞市場將調整產品結構 2-3年後可望發酵Anue鉅亨-2020/09/24
佳醫 相關文章
佳醫 相關影音